Marine Omega-3 Composition for Synergistic Anti-Inflammatory Activity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nutraceutical compositions using green-lipped mussel (GLM) powder as a source of ω-3 fatty acids often fail to meet the desired ω-3 content specification for maintaining joint health, necessitating the development of compositions that can elevate ω-3 levels to achieve effective anti-inflammatory activity.

Innovation Solution

A combination of hoki roe (HR) powder or oil with GLM powder or oil, ensuring a minimum 5% (w/w) HR content, enhances the ω-3 fatty acid content and exhibits a synergistic anti-inflammatory effect, surpassing the expected additive effect of individual components.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If green-lipped mussel (GLM) powder is used as a source of ω-3 fatty acids, then the composition provides a source of EFAs, but the ω-3 content is insufficient to meet the desired specification for maintaining joint health

Engineering Contradiction:
Improveω-3 fatty acid contentVSAvoidω-3 content specification reliability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent combines GLM powder with at least one additional marine source (such as hoki roe, paua, blue mussel, or king mackerel) to create a blended composition. This merging of multiple marine sources allows the composition to achieve sufficient ω-3 fatty acid content (at least 3.3% total ω-3 fatty acids) while maintaining reliability of meeting the specified requirements for joint health support.

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If high specification GLM powder is used to meet ω-3 content requirements, then the anti-inflammatory activity is improved, but the availability and ease of manufacture are reduced

Engineering Contradiction:
Improveanti-inflammatory activity reliabilityVSAvoidavailability of high specification GLM
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

Instead of relying solely on high specification GLM powder which is rare and difficult to source, the patent merges GLM with other marine sources that are more readily available. This approach maintains reliable anti-inflammatory activity (through synergistic effects) while improving ease of manufacture by using more accessible ingredients.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a composite marine ingredient blend combining multiple sources (GLM, hoki roe, paua, blue mussel, king mackerel) to achieve the desired functional properties. This composite approach allows for reliable anti-inflammatory activity through synergistic interactions while using ingredients that are easier to source and manufacture than high-specification GLM alone.

Inventive Principle:
Principle #40Composite materials

3Reliability

If the composition uses a blend of multiple marine sources, then the ω-3 content and anti-inflammatory effect are enhanced, but the composition complexity increases

Engineering Contradiction:
Improveanti-inflammatory effectVSAvoidcomposition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple marine sources in a standardized blend formulation. By establishing specific combination rules (at least two different marine sources, with GLM and at least one other source), the composition achieves enhanced anti-inflammatory effects through synergistic interactions while maintaining manageable complexity through defined formulation guidelines.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS12604918B2Synergistic compositions
Publication Date: 2026.04.21 LINTBELLS
  • US12604918B2 patent drawing
  • US12604918B2 patent drawing
  • US12604918B2 patent drawing

AI summary

The invention concerns novel compositions, comprising at least 2 different sources of ω-3 fatty acids, including wherein hoki roe at 5% (w/w) in powder or oil form and green-lipped mussel in powder or oil form. The compositions are particularly useful as/in supplements and/or animal or human food stuffs. The invention may further relate to the maintenance or treatment of human and veterinary conditions, such as use in the improvement of inflammation or joint related disorders that maybe associated with inflammation.